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A B S T R A C T 
Isolation of the corticosteroid-binding globulin CBG was achieved by 5 
chromatographical steps on Cortisol Sepharose, QAE-Sephadex A-50, Con 
A-Sepharose and hydroxylapatite. The purity of the isolated CBG was 
demonstrated in Polyacrylamide gel electrophoresis, SDS electrophoresis, 
immunodiffusion and ultracentrifligation. Microheterogeneity was shown 
in isoelectric focusing by 5 bands in the pH range of 3.7-4.2, which could 
be reduced to one major band after neuraminidase treatment. The equi-
molar binding of Cortisol to CBG was demonstrated by binding studies. 
The association constant for Cortisol was 2.8 χ ΙΟ8 Μ - 1 , for progesterone 
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I . 7 x l O ( 5 M _ 1 . From analytical ultracentrifugation, the molecular weight 
was calculated on 50 700; the sedimentation coefficient was 3.6 S, the 
partial specific volume 0.690 ml/g, the Stokes radius 38 Ä and the fric-
tional coefficient ratio 1.5. 
A sped lie radioimmunoassay for CBG was established using the purified 
CBG for immunization, radioiodination and for calibration standards. The 
normal range of CBG levels in human serum was 2.4-4.4 mg/100 ml 
(mean ± 2 SD) . Studies were performed to compare the levels of CBG and 
thyroxine-binding globulin (TBG). No sex differences but a significant 
biphasic age dependence were observed for both proteins. In pregnancy 
and under oestrogen treatment of women and men, CBG was demonstrated 
to be the more distinct indicator of oestrogenic activity as compared with 
TBG, whereas the sensitivity of TBG was more pronounced to supposedly 
antiestrogenic substances like Danazol, and in severe disease. No coin-
cidence of genetic CBG and TBG deficiencies have been found so far. 
I n h u m a n serum. Cortisol is bound to a specific transport protein, corticosteroid-
bind ing globulin (CBG) or transcortin, w i t h high aff ini ty and low capacity 
which migrates on paper electrophoresis as an alpha 1 -globulin. I n addition 
Cortisol is bound to a lbumin which has low aff in i ty , but high capacity (Daugha-
day I956a,b; Slaunwhite 8c Sandberg 1959; Slaunwhite et al. 1966; Middoon 
8c Westphal 1967). 
The concentration of CBG was un t i l now estimated by measuring the total 
b ind ing capacity of serum for Cortisol using gel f i l t ra t ion and equilibrium 
dialysis {De Moor el al. 1962; Murphy 8c Pattee 1963; Westphal 1971; Schwartz 
8: Hammerslein 1975; Angelt el al. J 977), and recently more specifically by 
radial immunodiffusion {Rosner el al. 1973; Racadot el al. 1974; Van Baelen 
8c De Moor 1974). There is major evidence that CBG has a buffer function for 
the biologically active free hormone fraction in blood {Slaunwhite et al. 1962; 
De Moor et al. 1963; Sandberg 8c Slaunwhite 1963), rather than an active 
transport function for steroid hormones to the target organ cell. But a possible 
role of proteins i n hormone-receptor interactions is also discussed {Westphal 
1971; Werthamer el al. 1973; Wong et al. 1973). The CBG concentrations in 
h u m a n serum have been estimated mainly under the aspect of oestrogen i n -
fluence {Sandberg 8c Slaunwhite 1959; De Moor el al. 1962; Doe el al. 1964; 
Schwartz 8c Hammer stein 1975) and genetic deficiency variat ions (Rosner el al. 
1973). 
Recently, characteristic changes of the thyroxine-binding globulin (TBG) 
have been demonstrated under the influence of different metabolic conditions 
{Horn et al. 1977; Horn 8c Gärtner 1979). Therefore, i t was investigated, 
whether parallelism in changes of these two different transport proteins, CBG 
and T B G could be detected. 
For this purpose CBG had to be isolated from human serum and a specific 
method for its determination had to be established. 
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Μ Α Τ Ε R I A L S A N D Μ Ε Τ H O D S 
Reagents. - Pure Cortisol was purchased from the Merck AG, Darmstadt, FRG, [·5Η] 
Cortisol (110 mCi/mg Cortisol) from the Radiochemical Center in Amersham, England, 
and Cortisol hemisuccinate from Sigma Chemical Company, St. Louis, USA. Sodium1- r > 
iodide (10 Ci/mg 1) came from the Hoechst AG, Frankfurt, FRG. AH-Sepharose 4B 
for affinity chromatography, Con A-Sepharose, QAE-Sephadex A-50 for ion exchange 
chromatography and Sephadex G-10 were obtained from Pharmacia Fine Chemicals, 
Uppsala, Sweden. The hydroxylapatite Biogel HTP was purchased from Bio-Rad 
Laboratories, Richmond, USA. Florisil, acrylamide and bovine gamma globulin were 
obtained from the Serva Biochemica, Heidelberg, FRG. Sodium Lauryl Sulphate (SDS) 
from Sigma Chemical Company, St. Louis, USA. Bovine albumin and alpha-methyl-
D-mannoside from Roth, Karlsruhe, FRG, neuraminidase (Clostridium perfringens) 
from Boehringer Mannheim GmbH. The following reagents came from the Merck AG, 
Darmstadt, FRG: N-ethyl-N'-ivS-dimethylaminopropylJ-carbodiimide-hydrochlorid, po-
lyethylenglycol 6000, complete Freund's adjuvant and all reagents (pro-analysis grade) 
for the preparation of the buffer solutions. Human transferrin and pertussis vaccine 
were obtained from the Behringwerke, Marburg, FRG. The human plasma anti-
coagulated with acid-citrate-dextrose (ACD) was freshly obtained from the blood bank 
and immediately used for preparation. 
Isoelectric focusing. - Isoelectric focusing studies (Radola Sc Graesslin 1977) of 
isolated CBG were performed in slab gels (16x0.4 cm), using LKB equipment (LKB 
produkter, Bromma, Sweden). The concentrations of Polyacrylamide and Ampholine® 
solutions pH 3.5-5.0 and pH 3.5-10 respectively (LKB produkter) were each 5 % (v/v). 
After isoelectric focusing (500 V, 20 W, 6 hours) gels were either stained using bromo-
phenol blue or cut in slices of 0.5 cm. After elution with destilled water by diffusion 
pH-values were measured with a m.icroelectrode, the CBG-concentrations by radio­
immunoassay and [ : 5H] Cortisol in a /i-scintillation counter. 
Isolation of CBG from human plasma 
Affinity chromatography. - Using a modification of the method described by 
Cuatrecasas (1970), 2 g Cortisol hemisuccinate (=4.1 mmol) dissolved in 50 °/o dime-
thylformamide were covalently bound to 15 g AH-Sepharose 4B (=0.48 mmol amino 
groups) by activation with 2.17 g carbodiimide (= 10 mmol) for 20 h at room tempera­
ture. The Cortisol Sepharose was then washed alternatively with 1 Μ glycine and 0.2 Μ 
Tris-HCl buffer pH 8.6. From 5 liters human plasma the endogenous steroids were 
removed by 50 g llorml. Then, plasma and Cortisol Sepharose were stirred for 30 min 
at room temperature and for 60 min at 4°C. The plasma was then filtered, the gel was 
washed with 1000 ml cold 0.2 Μ Tris-HCl buffer pH 8.0 and packed in a water-
jacketed column. From this column CBG was eluted by elevation of the temperature 
up to 30°C with 20 mg Cortisol hemisuccinate in 100 ml 0.16 Μ NaCl in 0.05 Μ Tris-
HCl buffer pH 8.6. 
Purification of CBG by column chromatography techniques 
The following purification steps were performed at 4°C. The CBG peak from Cortisol 
Sepharose was given on a QAE-Sephadex A-50 column (4.2 χ 24 cm) which was 
equilibrated with 0.18 Μ NaCl in 0.05 Μ Tris-HCl buffer pH 8.6. After washing the 
gel with one column volume of starting buffer, CBG was eluted by the elevation of the 
NaCl concentration up to 0.22 Μ in 0.05 Μ Tris-HCl buffer ρ Η 7.4 in a volume of 
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90 ml. This CBG peak was transferred on a Con A-Sepharosc column (3 .2x22 cm). 
The column was washed with one column volume of 0.05 Μ sodium phosphate bulier 
pH 7.4 and CBG eluted with 0.06 Μ alpha-methyl-D-mannoside in the same buffer. 
This CBG peak of 70 ml was dialyzed and concentrated in a collodion bag. The 
following chromatography was performed on a hyclroxylapatite column (1 .2x45 cm) 
equilibrated with 0.001 Μ sodium phosphate buffer pH 6.8. The same buffer was used 
for the elution step. The CBG peak was concentrated and transferred to a QAE-
Sephadex A-50 column (2 .2x45 cm), equilibrated with 0.19 Μ NaCl in 0.05 Μ Tris-
H C l buffer pH 8.6. The final elution was performed with a linear gradient (400 ml) 
from 0.19 to 0.24 Μ NaCl in 0.05 Μ Tris-HCl buffer 8.6 in a volume of 75 ml. The 
CBG solution was repeatedly dialyzed in a collodion bag against aqua bidest., frozen, 
lyophilized and stored at - 20°C. The CBG peaks in the eluates from each column were 
identified using a modification of the [:*H]cortisol-uptake-test on 5 ml Sephadex G-50 
{Horn et al 1975). 
Radioimmunoassay of CBG 
Immunization. - Rabbits were immunized with 120 ug CBG in complete Freund's 
adjuvant and 0.5 ml pertussis vaccine antigen using a multiple intradermal injection 
technique (50 sites) on the back flanks. They were boosted every three weeks with the 
same technique. 
Radioiodinalion of CBG was done with the chloramine-T-method {Greenwood et al 
1963). The separation of the CBG tracer was performed only on a 1 ml Con A-
Sepharose column. The CBG tracer was eluted with 0.06 Μ alpha-methyl-D-m.annoside 
and diluted in 2 g/1 bovine albumin in 0.05 Μ sodium phosphate buffer pH 7.4. The 
tracer could be used for 8 weeks without further purification. 
For the radioimmunoassay 100 μ\ CBG standard solution or 1:100 diluted serum 
were incubated with 100 μ] CBG tracer and 100 μ\ diluted CBG antiserum. The 
bound/free-separation could be performed by the polyethylene glycol precipitation 
{Desbuquois Sc Aurbac/i 1971) or the double antibody technique. 
R Ε S U L Τ S 
Criteria of purity and characterization 
Elerlrophorclical methods. - The isolated CBG migrated on Polyacrylamide 
gel electrophoresis and SDS electrophoresis {Maurer 1971) each performed in 
two different buffer systems p H 8.9 and p H 7.0 and three different gel con­
centrations (10, 7.5 and 5%) in one homogeneous band. Immunoelectrophoresis 
and Ouchterlony double diffusion test demonstrated a single precipitation line 
between CBG antiserum and CBG solution and normal human serum, respec­
tively. The overlapping of both precipitation lines indicated identi ty between 
endogenous and isolated CBG. 
Isoelectric focusing studies revealed a microheterogeneity of 5 different 
bands in the p H range of p H 3.7-4.2. I n the same p H area CBG was detected 
in the radioimmunoassay as wel l as the radioactivity of [ 3 H ] Cortisol pre-
incubated w i t h CBG. Neuraminidase treatment of CBG reduced the micro-
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heterogeneity to one major and one minor band in the p H range of p H 6.0 
(Fig. 1). 
Analytical ultracenlrif ligation. — The puri ty and the homogeneity of the 
isolated CBG could be demonstrated by a homogeneous curve in sedimentation 
velocity runs and by a straight line in the high speed sedimentation equilibrium 
runs. The sedimentation coefficient corrected to 20° C and water {Schachmann 
1957; Schachmann 8c Edelstein 1966) was calculated to be 3.6 S. Considering 
a part ia l specific volume of 0.690 ml /g derived from the amino acid and 
carbohydrate composition (Table 1) a molecular weight (Yphantis 1964) of 
50 700 ± 2500 (n = 4) for CBG was determined. The diffusion coefficient was 
calculated to be 5.6 D , the Stokes radius 38 A and the frict ional coefficient 
ratio 1.5. 
Quantitative amino acid analysis in two different CBG preparations is sum-
marized i n Table 1. The high content of aspartic acid and glutamic acid 
explains the low isoelectric point of CBG. The carbohydrate composition is 
shown in the lower part of Table 1. 
pH 5.0 10.0 
f 
pH 3 .5 3.5 
Fig. L 
Isoelectric focusing of isolated CBG. Left: untreated CBG, pH gradient 3.5-5.0. Right: 
Desialylated CBG (0.03 U/ml neuraminidase, acetate buffer pH 5.6. 30 min) pH gradient 
3.5-10. 
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Table I . 
Amino acid and carbohydrate composition of CBG. The amino acid analysis was 
performed with two different preparations of CBG, the carbohydrate analysis only 
with one preparation. Assuming a molecular weight of 50 700 the left column indicates 
the numbers of amino acid residues per mol CBG, the right column the percentage 
of the single amino acids of the polypeptid residue (molecular weight 32 950). The 
lower part of the table indicates the carbohydrate composition of the second preparation 
of CBG. 
amino acids: No. of residues/mol CBG δ­
of residue/100 g 
of polypeptid 
preparation I I I ι I I 
Lysine 15 15 6.7 6.7 
Histidine 11 12 5.2 5.7 
Arginine 10 10 5.3 5.3 
Aspartic acid 35 37 14.1 14.9 
Threonine 18 17 6.5 6.1 
Serine 21 16 6.7 5.1 
Glutamic acid 33 34 14.7 15.2 
Proline - 8 - 2.7 
Glycine 11 10 2.5 2.2 
Alanine 14 15 3.7 4.0 
Cystine - - - -
Valine 18 21 6.4 7.4 
Methionine 12 11 5.4 5.0 
Isoleucine 15 18 5.9 7.1 
Leucine 35 39 13.9 15.5 
Tyrosine 13 9 7.1 4.9 
Phenylalanine 23 25 11.8 12.8 
carbohydrate compos tion 
in % by weight 
I I 
Mannose 9.5 
Galactose 5.3 
Glucosamine 10.3 
Sialic acid 10.0 
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Bijiding of steroid hormones to the isolated CBG 
The b inding of several steroids to CBG was investigated by two different 
methods, f i rs t ly equil ibr ium dialysis in micro-cells (Dianorm Apparatus, D i a -
chemica A G , Switzerland) as the reference method and secondly, gel f i l t ra t ion 
on small columns w i t h 2 m l Sephadex G-10 as a very simple method for 
estimation of the relative af f in i ty constants of several steroids. The binding 
studies were performed in phosphate buffer p H 7.4 at 4° C. The incubation 
time for gel f i l t ra t ion was 15 min , the dialyzing time 8 h. Equi l ibr ium dialysis 
was performed for four different steroids using f i rs t ly the corresponding tracer 
and secondly [ 3 H ] Cortisol i n order to test for cross reactivity between the 
different steroids and Cortisol tracer i n C B G binding. There was a large 
measure of agreement between the calculated binding constants of each method 
(Table 2). Gel f i l t r a t ion resulted in lower association constants than equil i­
br ium dialysis. This was due to the disturbance of equil ibr ium during the 
f i l t ra t ion on Sephadex G-10. The binding constant for Cortisol was found to 
be approximately 8 times lower in gel f i l t ra t ion than in equil ibrium dialysis. 
U t i l i z i n g this factor for the correction of the association constants of 17a-
hydroxy-progesterone, 11-deoxyCortisol, progesterone and testosterone, each 
calculated by displacement of [ 8 H ] Cortisol using gel f i l t ra t ion , the corrected 
0.4-
0,2-
Scatchard Plot 
b= 2 . 2 x 1 0 8 
r = 0.97 
ι 
1,5 2,5 bound Cortisol 
[ nM ] 
Fig. 2. 
Determination of the association constant of Cortisol and isolated CBG by means of 
Scatchard plot. Ordinate: ratio of CBG bound and free Cortisol tracer. Abscissa: amount 
of bound Cortisol, calculated as product of the percentage of [ 3 H] Cortisol (B/T) and 
the molecular concentration. 
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Table 2. 
Association constants of different steroids, determined by equilibrium dialysis using 
the corresponding tracer for each steroid (first column), equilibrium dialysis using 
[ 3 H ] Cortisol tracer only (second column), and gel filtration on Sephadex G-10 using 
[ 3H]Cortisol tracer only (third column). 
For methodological details see text. In the right part of the table the molecular dif­
ferences of the investigated steroids compared with Cortisol are indicated. 
a s s o c i a t i o n constants CM*1] 
molecular differences compared with Cortisol 
— pregnane structure *-
steroid 
equi l ibr ium 
dialysis 
ge l 
filtration 
Δ 1 
d
eh
yd
ro 
ο ο ο 
m 
5 £ 
η ? . 
α 
ο 
ο ο 
" 5 
τ. 
• Ι 
5' 
_. > 
: ι 
α 
A
n
d
ro
-
stene 
stru
ctu
re 
Fluorine 
in 9 oc 
Est rogene 
S
tructure 
Cortisol 
Correspond irx 
Tracer 
2.2 Χ 1 0 8 
; Cortisol 
Tracer 
2.2x10 ö 2.2χ10 β 
h
ig
h
 
affin
ity 
Prednisolone 5.4χ10 7 • 
h
ig
h
 
affin
ity 
Corticosterone 5 . 0 Χ 1 0 7 • hig
h
 
affin
ity 
17a -Medroxy­
progesterone 5.3 χ 10
7 4.9χ10 7 2 8 χ 1 0 7 • • 
h
ig
h
 
affin
ity 
11 -Deoxy -
Cortisol 1.3 χ 10
7 1 6 χΙΟ 7 2.8χ10 7 • 
h
ig
h
 
affin
ity Deoxy cortico­
sterone 2 2 χ 1 0
7 • • 
h
ig
h
 
affin
ity 
Cortisol -
21 - succinate 1.6 χ 10
7 • 
m
o
d
erate affinity 
Cortisone 7.2 χ 10* • mod
erate affinity 
Methyl -
prednisolone Αθχ 10
6 • • 
m
o
d
erate affinity 
Progesterone 17 χ 10 β 5.7>. 10 6 Α.1 χ 10 6 • • • 
m
o
d
erate affinity 
Prednisone 3.4χ10 6 • • 
m
o
d
erate affinity Aldosterone 2 6χ 10
6 • • 
m
o
d
erate affinity 
Testosterone 2.5 χ 10β 2.9χ10 β 16 χ 106 • 
low
 
affin
ity 
9 a - Fluoro -
hydrocortisone 5.6χ10
4 • low
 
affin
ity 
Es t r io l 2 Λ χ 1 0 4 • 
low
 
affin
ity 
E s t r a d i o l 2 3 χ 1 0 4 • 
low
 
affin
ity Triamcinolone -
acetonid 1.6 χ 10* • 
no affinity Dexamethasone, Ethinylestradiol, Carbenoxolone 
values were in the same order of magnitude as found in the equil ibrium dia­
lysis (Table 2). The maximal binding capacity calculated by Scatchard analysis 
was found to be 715 tug Cortisol per 100 mg CBG indicating an equimolar 
b inding of CBG and Cortisol (Fig. 2). By comparing the association constants 
w i t h the molecular differences of several steroids to Cortisol (Table 2) i t might 
be supposed that the binding aff in i ty decreased in dependence on the electron 
attraction and the size of the substitute. 
377 
Radioimmunologlial determination of CBG. - The antiserum w i t h the highest 
titer of 1:160 000, determined by 50% tracer binding, was obtained after the 
th i rd booster. The maximal tracer binding (specific act ivi ty: 31 / /Ci / / /g CBG) 
was nearly 100%. The nonspecific binding without antiserum in the reaction 
mixture was in the range between 5 to 10%. Using an antiserum di lu t ion of 
1:3000 the l imi t of detection (3 SD from the zero standard) was 2 ng CBG per 
tube. The 5 0 % intercept was 24 ng CBG per tube, the recovery of added CBG 
standard in serum was 100%. di lu t ion curves of normal and pregnancy sera 
were found to be exactly on the calibration curve. The interassay variation 
coefficient was 7.4%) (mean 3.3 mg/100 m l ; η = 23). 
There was no evidence for cross reactivity of CBG antiserum w i t h alpha.>-
macroglobulin, alphao-haptoglobin, alpha!-antitrypsin and albumin in the 
Ouchterlony double diffusion test, cross reactivity of TBC* was excluded in the 
radioimmunoassay. Cortisol in serum had no effect on the results of CBG 
determination. 
Comparison of CBG and TBG levels in human serum 
CBG levels in human serum. - I n 40 control persons between the ages of 
15-50 years the range of serum CBG was 2.4-4.4 mg/100 ml . CBG levels of 
patients wi th Cushing's syndrome (n = 4) and Addison's disease (n = 4) were 
C B G 
(mg /100ml) 
A T B G 
[mg/100 m l ] 
< 5 <15 1 5 - 5 0 >50 years 
age dependence 
Fig. 3. 
Age dependence of CBG and TBG levels. Hatched columns: CBG levels in mg/100 ml. 
Open columns: TBG levels in mg/100 ml. Hatched lines indicate the normal range 
of CBG and TBG in controls in the age of 15 to 50 years. I mean db so. 
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C B G 
[ m g / 1 0 0 m l ) 
1 T B G 
[mg/100ml]r 
CBG and TBG levels of 4 women subsequently treated with 4 different oestrogen 
preparations. The hatched columns: CBG levels, the open columns: TBG levels. The 
hatched lines represent the normal ranges of CBG and TBG for the age from 15 to 50 
years. 
found in this range. I n 134 healthy controls the CBG levels showed a biphasic 
age dependence of CBG levels (Fig. 3). Significant sex differences of CBG 
and T B G levels could not be ascertained in any period of l ife. 
Oestrogen dependence of CBG and TBG. - I n pregnancy CBG as well as 
T B G levels increased continuously and reached a plateau during the third 
trimenon (6.9 ± 0.24 mg/100 ml , η - 16). 
The effect of exogenous oestrogens on CBG and T B G levels was investigated 
in four ovarectomized women (Fig. 4). The patients were subsequently treated 
wi th mestranol (80 //g/day), ethinyl oestradiol (80 //g/day), oestradiol valer i ­
anate (40 mg/14 days), and oestriol (2 mg/day), each preparation for four 
weeks. 
Between the phases of oestrogen therapy, a period of placebo administration 
was inserted for 4 weeks. The response of CBG to oestrogens was more 
pronounced than the T B G increase. The maximal increase for both was ob­
served after mestranol, whereas oestriol had no effect (Fig. 4). I n 10 male 
379 
patients undergoing fosfestrol treatment (Honvan®) for a prostatic carcinoma, 
a dose-related elevation of CBG levels was observed. Both, CBG and T B G 
levels reached values of females treated w i t h oestrogens, and again CBG was 
shown to be the more sensitive indicator of oestrogenic activity. 
CBG levels in TBG deficiency stales. - T B G deficiency was induced by 
treatment w i t h Danazol (2,3-isoxazol-derivative of ethinyl-testosterone, 
Win th rop , Gießen , FRG). Fifteen women were treated w i t h 400 mg Danazol/ 
day for endometriosis, since Danazol is known to induce endometrium atrophy, 
and to suppress ovulation and midcycle peaks of gonadotrophins and oestradiol, 
whereas the mean basal values of L H and oestradiol remain constant (Goebel 
& Rjosk 1978). The T B G levels were decreased to 50 °/o of the in i t i a l values 
after four weeks of therapy, whereas the CBG levels d id not change signi-
ficantly even after 12 weeks (Fig. 5). 
I n 7 patients w i th severe chronic diseases such as decompensated l iver cir-
rhosis and chronic heart failure, T B G levels were found to be decreased to 
0.72 ± 0.23 mg/100 m l . This was interpreted as symptomatic T B G deficiency. 
I n these patients the mean CBG levels were decreased as wel l to 2.6 ± 1 . 0 mg/ 
100 m l . But the decrease of CBG was less pronounced than that of T B G . 
I n nine patients (8 men and 1 female) wi th genetic T B G deficiency (0.4 ± 0.3 
mg/100 ml , ± SD), CBG levels were found to be in the normal range. 
C B G 
1 mg/100 m l ] 
i TBG [mg/100ml) 
mg 
before A 8 12 weeks after 
Danazol - therapy 
Fig. 5. 
CBG and TBG levels during Danazol therapy. Hatched columns: CBG levels, open 
columns: TBG levels. The hatched lines represent the normal range of CBG and TBG 
for the age from 15 to 50 years. 
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D I S C U S S I O N 
The principle of a f f in i ty chromatography as described by Cualrecasas (1970) 
and used at first by Rosncr 8c Bradlow (1971) for the isolation of CBG was 
modif ied in our study. 
Al though Rosncr 8c Bradlow (1971) performed the coupling of Cortisol 
hemisuccinate in pure dioxane and Le Gaillard el al. (1974) thought the coup-
l i n g in 5 0 % dimethylformamide not to be practicable, we found that the best 
results were obtained wi th the latter method. For displacement of CBG from the 
Cortisol Sepharose, Cortisol hemisuccinate addit ion to the elution buffer was 
preferred in order to avoid possible denaturation of CBG which may occur i f 
more aggressive eluents are used. 
The observation of Rosner 8c Bradlow (1971) who found only CBG and 
gamma globulins in the eluate of the af f in i ty chromatography column could 
not be confirmed. Therefore, several addit ional chromatographic purification 
steps were required. The overall y ie ld of 2 0 % after 5 different preparatory 
steps was satisfactory. The pur i ty of the isolated CBG was shown by a single 
band in overloaded Polyacrylamide and SDS electrophoreses and by ul t ra-
centrifugation studies. 
The properties of CBG ascertained in our laboratory agreed for the most 
part w i th the results of other authors. The molecular weight is reported to be 
in the range of 49 500 to 58 500 {Slaunwhite el al. 1966; Muldoon 8c Westphal 
1967; Le Gaillard et al. 1975). By ultracentrifugation, we determined the value 
of 50 700, the sedimentation coefficient of 3.6 S and the part ial specific volume 
of 0.690 ml /g , which corresponds to the values published by Westphal (1971). 
The hydrodynamic parameters part icular ly the frict ional coefficient ratio sug-
gest that CBG can s t i l l be regarded as a globular protein. The Stokes radius of 
the molecule is about 38 Ä which corresponded wel l w i t h other proteins w i t h 
a molecular weight i n this range. The association constants for Cortisol and for 
other steroids par t ia l ly obtained by two different methods agreed wel l w i t h 
the literature {Westphal 1977; Stroupe el al. 1978). Only the aff in i ty of pro-
gesterone to CBG was found to be lower {Westphal 1971). 
The carbohydrate content of 35% by weight and the mean N-acetylneura-
minic acid content of approximately 16 residues per mol isolated CBG was 
surprisingly high as compared wi th the literature {Slaunwhite el al. 1966; Le 
Gaillard et al. 1975; Rosner 1976). 
Af te r treatment w i t h neuraminidase the microheterogeneity of CBG consist-
ing of 5 single bands was focused to one major band into the alkaline direction. 
The residual more acidic minor band may be due to incomplete desialylation. 
Therefore the microheterogeneity of CBG may be due only to the different 
N-acetylneuraminic acid content as is already established for other glyco-
proteins and as recently shown for T B G {Horn 8c Gärtner 1979). 
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Radioimniunological quantitation of CBG in scrum. - Al though Rosner el al. 
(1973) and Van Baelen Sc De Moor (1974) preferred the subcutaneous or in t ra-
muscular application technique using a ten-times higher amount of CBG, a 
monospecific antiserum was obtained by the intracutaneous injection of ap-
proximately 120 //g CBG. As the precision and practicability of the radioim-
munoassay was satisfactory, the method was preferable to the radial immuno-
diffusion technique (Rosner el al. 1973; Racadol el al. 1974: Van Baelen Sc De 
Moor 1974) for measuring CBG concentrations. 
The CBG levels in serum of healthy adults corresponded well w i t h the 
values estimated by the earlier published methods (Westphal 1971; Rosner et al. 
J973; Racadol ct al. 1974: Van Baelen Sc De Moor 1974; Rosner 1976). 
CBG levels in normal controls. - Elevated binding capacities of CBG in 
serum have been observed in newborns and infants by several authors (De 
Moor et al. 1962; Angeli el al. 1977; Wagner 1978). These findings could now 
be ascertained by the direct CBG radioimmunoassay and in addition a further 
increase of CBG was seen in elder subjects. This biphasic age dependence was 
parallel w i th the T B G levels (Horn el cd. 1977). Sex differences of CBG or 
T B G levels could not be ascertained in any period of life. These results were 
surprising wi th regard to the known oestrogen influence on the levels of both 
proteins, therefore apart from the well known oestrogen induced increase of 
both transport proteins supposedly other factors have an influence on CBG 
and T B G . 
Oestrogen dependence of CBG and TBG levels. - The oestrogen induced i n -
crease of CBG and T B G levels, wel l known from earlier investigations (Doe et al. 
1964; Sandberg Sc Slaunwhile 1959; Jngbar 1971; Horn el al. 1977; Wagner 1978). 
was now ascertained by the quantitative and specific radioimmunological 
determination. The investigation of sera in pregnancy and during oestrogen 
therapy of women and men demonstrated a more pronounced increase of C B G 
as compared wi th T B G . The increase is probably due to an augmented syn-
thesis of this protein as the half- l i fe is identical in controls and oestrogen 
treated persons (Sandberg el al. 1964). After therapy of four women w i t h sup-
posedly equivalent doses of four different oestrogen preparations, no increase 
of CBG and T B G was found after oestriol. As expected, the increase was 
significantly higher after ethinyloestradiol as compared wi th oestradiol 
valerianate. Surprisingly the most pronounced increase was induced by me-
stranol. which may be due to its hepatic metabolism (Bird Sc Clark 1973). 
CBG levels in TBG deficiency stales. - Dur ing Danazol therapy, only a 
decrease of the T B G levels was observed, while the CBG levels did not change. 
Dur ing the Danazol therapy, clinical signs of peripheral oestrogen deficiency 
were observed despite of normal oestradiol levels. There is possibly an inter-
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ference of Danazol and oestrogens on liver cell receptors, which effects only 
T B G decreases. Likewise, the decrease of T B G levels in catabolic states was 
more pronounced than that of CBG. These differences in the behaviour of 
CBG and T B G under various hormonal and metabolic influences cannot yet 
be explained. 
No coincident genetic defects of the two different transport proteins have 
been observed. 
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